Alnylam Pharmaceuticals
ALNY
#503
Rank
HK$375.94 B
Marketcap
HK$2,846
Share price
-0.53%
Change (1 day)
51.94%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Market capitalization of Alnylam Pharmaceuticals (ALNY)

Market cap: HK$375.94 Billion

As of January 2026 Alnylam Pharmaceuticals has a market cap of HK$375.94 Billion. This makes Alnylam Pharmaceuticals the world's 503th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Alnylam Pharmaceuticals from 2004 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$375.94 B-8.7%
2025HK$411.77 B72.81%
2024HK$238.28 B27.02%
2023HK$187.60 B-17.88%
2022HK$228.44 B44.45%
2021HK$158.14 B35.1%
2020HK$117.05 B16.33%
2019HK$100.62 B74.2%
2018HK$57.76 B-41.32%
2017HK$98.44 B295.12%
2016HK$24.91 B-59.87%
2015HK$62.08 B6.89%
2014HK$58.08 B82.76%
2013HK$31.78 B328.03%
2012HK$7.42 B174.54%
2011HK$2.70 B-16.76%
2010HK$3.24 B-43.16%
2009HK$5.71 B-27.78%
2008HK$7.91 B-14.39%
2007HK$9.24 B49.91%
2006HK$6.16 B208.73%
2005HK$1.99 B78.44%
2004HK$1.11 B

End of Day market cap according to different sources

On Jan 14th, 2026 the market cap of Alnylam Pharmaceuticals was reported to be:

HK$377.95 Billion
by Nasdaq info icon info icon
HK$377.95 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Arrowhead Pharmaceuticals
ARWR
HK$72.46 B-80.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Regeneron Pharmaceuticals
REGN
HK$615.78 B 63.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
HK$17.96 B-95.22%๐Ÿ‡บ๐Ÿ‡ธ USA
OPKO Health
OPK
HK$7.95 B-97.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Regulus Therapeutics
RGLS
HK$4.40 B-98.83%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$2.138 T 468.91%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Sanofi
SNY
HK$892.88 B 137.50%๐Ÿ‡ซ๐Ÿ‡ท France
Teva Pharmaceutical Industries
TEVA
HK$291.03 B-22.59%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel